A former employee of two Alabama doctors convicted of
operating a pill mill may not intervene in their criminal case
to claim a cut of funds they forfeited as a reward for pursuing
a related whistleblower case, a federal appeals court has ruled.
A federal jury has awarded the family of a deceased West
Virginia woman $1.25 million after finding that Boehringer
Ingelheim misrepresented the risks of its blood thinner Pradaxa,
causing her to suffer gastrointestinal bleeding.
A federal judge in Philadelphia has taken the unusual step
of ordering the unsealing of a whistleblower lawsuit accusing a
compounding pharmacy of defrauding government healthcare
programs despite requests by the U.S. Justice Department to keep
the case sealed.
A federal judge has rejected motions by 20 drug companies
including Mylan NV and Teva Pharmaceutical Industries Ltd to
dismiss lawsuits accusing them of conspiring to raise the prices
for six generic drugs including the common antibiotic
Minnesota's attorney general on Tuesday filed a lawsuit accusing drug manufacturers Sanofi SA, Novo Nordisk and Eli Lilly and Co of deceptively raising prices for insulin.
A federal judge has nearly doubled how much must be held
back from any settlements with testosterone replacement drug
manufacturers to potentially compensate plaintiffs lawyers for
working on matters related to the mass tort litigation.
A federal appeals court has overturned the certification of
a class of purchasers of Asacol, an ulcerative colitis drug, who
accused drug manufacturer Warner Chilcott, now owned by Allergan
PLC, of suppressing generic competition for the medication.
BOSTON A former State Street Corp executive was sentenced on Tuesday to 18 months in prison after being convicted of taking part in a scheme to overcharge customers of the bank by applying secret commissions on billions of dollars' worth of trades.
BOSTON Harvard University discriminates against Asian-American applicants in order to limit how many it admits, a lawyer for a group suing the school said on Monday at the start of a trial that could have wider implications for the role of race in U.S. college admissions. | Video
Theranos Inc founder Elizabeth Holmes and ex-president
Ramesh "Sunny" Balwani have lost their bid to block prosecutors
from continuing to enforce a grand jury subpoena issued to the
failed Silicon Valley blood-testing startup.